Experience

Volastra Therapeutics

• United States
• Biotechnology
• 1 - 100 Employee

• Senior Laboratory Manager, Scientist II

  • Jan 2022 - Present

• Laboratory Operations Manager

  • Jul 2020 - Present

  Laboratory Operations Manager at Volastra Therapeutics



Inzen Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Laboratory Operations Manager

  • Oct 2018 - May 2020

  Manage daily laboratory and office operations, as well as provide quick turnaround for research project needs. Liaise with Finance and Procurement departments, vendors, CRO's, building Facilities and Management; led BSL2 lab build-out; managed safety/compliance; wear multiple hats with the goal of keeping all the balls rolling. Manage daily laboratory and office operations, as well as provide quick turnaround for research project needs. Liaise with Finance and Procurement departments, vendors, CRO's, building Facilities and Management; led BSL2 lab build-out; managed safety/compliance; wear multiple hats with the goal of keeping all the balls rolling.



Columbia University in the City of New York

• Higher Education
• 1 - 100 Employee

• Laboratory and Grant Manager for the Yuste Lab and NeuroTechnology Center at Columbia University

  • Feb 2015 - Sep 2019

  Managed the daily operations of a ~15-person mouse neuroscience laboratory, as well as project and personnel management, grant writing and administration, conference organization, mouse colony management and procedures for neuroscience endpoints.

• Adjunct Associate Research Scientist, Hunt Lab

  • Mar 2014 - Feb 2015

  Investigated the factors governing exogenous protein expression levels in E. coli. Published results in Nature in January 2016.



Columbia University

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Mar 2011 - Jul 2012

  Mechanism of action studies for bioactives discovered through small molecule screening.

• PhD, Biological Sciences

  • Sep 2004 - Mar 2011

  Thesis title: Investigating neurodegenerative diseases with small molecule modulators

• Graduate Student

  • Sep 2004 - Mar 2011

  Developed high-throughput screen to identify small molecules upregulating the Survival of Motor Neuron (SMN) protein in patient fibroblast cells. Mechanism of action studies revealed that the Ras protein is a strong modifier of SMN protein levels. Published in ACS Chemical Biology: http://www.ncbi.nlm.nih.gov/pubmed/23496866